Research | OneLook Acronym Finder |
Serial Number | 79304754 |
Registration Number | 6617276 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Law Office Assigned | M30 |
Employee Name | JENKINS JR, CHARLES L |
2020-09-15 | Application Filed |
2021-02-23 | Location: TMO LAW OFFICE 112 |
2021-02-23 | Status: Live/Pending |
2021-02-23 | Transaction Date |
2022-01-18 | Trademark Registered |
Owner: | CLOSED LOOP MEDICINE LTD |
Entity Statement | Limited Company |
Address | The Babraham Research Campus, Babraham Hall, Babraham CAMBRIDGE CB22 3AT GB |
Legal Entity Type | |
Legal Entity State | GB |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
International Codes: | 9 |
U.S. Codes: | 021,023,026,036,038 |
International Codes: | 10 |
U.S. Codes: | 026,039,044 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | Drugs for medical use; drugs for medical purposes; pharmaceutical drugs; pharmaceuticals; therapeutic drugs and agents; pharmaceuticals and natural remedies; medical preparations for humans; pain relief medicines; medicines; medicines for the treatment of sleep disturbance; medicines for the treatment of hypertension; medicines for the treatment of metabolic disorders; parts and fittings for all of the aforesaid goods (terms considered linguistically incorrect by the International Bureau - rule 13 (2) (b) of the Regulations) |
GS0051 | Pharmaceutical preparations for the treatment of sleep disorders, hypertension, chronic pain, metabolic disease, mental health, anxiety, depression, psychosis, endocrine conditions, thyroid disorders, inflammatory disorders, polymyalgia rheumatica; Medical preparations for the treatment of sleep disorders, hypertension, chronic pain, metabolic disease, mental health, anxiety, depression, psychosis, endocrine conditions, thyroid disorders, inflammatory disorders, polymyalgia rheumatica; pain relief medication; medicines for the treatment of sleep disturbance; medicines for the treatment of hypertension; medicines for the treatment of metabolic disorders |
Description | Date | Event Coding |
---|---|---|
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2021-02-18 | 1 REPR M: |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-02-23 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2021-02-23 | 3 DOCK D:Assigned to Examiner |
APPLICATION FILING RECEIPT MAILED | 2021-02-27 | 4 MAFR O:Outgoing Correspondence |
NON-FINAL ACTION WRITTEN | 2021-03-08 | 5 CNRT R:Renewal |
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2021-03-09 | 6 RFCR E:E-Mail |
REFUSAL PROCESSED BY MPU | 2021-03-15 | 7 RFRR P: |
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2021-03-15 | 8 RFCS P: |
REFUSAL PROCESSED BY IB | 2021-04-05 | 9 RFNT P: |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2021-09-09 | 10 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-09-09 | 11 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-09-10 | 12 TEME I:Incoming Correspondence |
EXAMINERS AMENDMENT -WRITTEN | 2021-09-24 | 13 CNEA R:Renewal |
EXAMINERS AMENDMENT E-MAILED | 2021-09-24 | 14 GNEA O:Outgoing Correspondence |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2021-09-24 | 15 GNEN O:Outgoing Correspondence |
EXAMINER'S AMENDMENT ENTERED | 2021-09-24 | 16 XAEC I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-09-30 | 17 CNSA O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-10-13 | 18 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2021-11-02 | 19 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-11-02 | 20 NPUB E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2022-01-18 | 21 R.PR A:Allowance for Publication |
NEW REPRESENTATIVE AT IB RECEIVED | 2022-04-02 | 22 NREP P: |
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2022-04-18 | 23 FICR P: |
FINAL DISPOSITION PROCESSED | 2022-06-29 | 24 FIMP P: |
FINAL DISPOSITION NOTICE SENT TO IB | 2022-06-29 | 25 FICS P: |
FINAL DECISION TRANSACTION PROCESSED BY IB | 2022-07-18 | 26 FINO P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.